- Deciding which activities should remain in-house
- Selecting specialist CROs and niche vendors
- Managing oversight without increasing internal headcount
- Building long-term outsourcing partnerships
- Recognising early warning signs
- Recovery strategies
- Working with sites and CROs
- Lessons learned
- Building partnerships with specialist rare disease centres and referral networks
- Working with centres of excellence to identify patients earlier
- Balancing international recruitment with long-term site relationships
- Strengthening collaboration across investigators, advocacy groups and specialist networks
- Coordinating multiple operational partners
- Managing increasingly complex protocols
- Keeping timelines on track
- Lessons learned from recent oncology studies
- Prioritising programmes when resources are limited
- Allocating people across competing studies without creating bottlenecks
- Balancing speed, quality and cost across the portfolio
- Knowing when additional resource will genuinely improve delivery
- Practical approaches to portfolio-level resource planning
